With Special Packaging, Sagent Gets FDA Approval For Heparin Products

0 comments

Posted on 6th July 2010 by gjohnson in Uncategorized

, , , , ,

In a much publicized case, actor Dennis Quaid’s newborn twins were accidentally given heparin overdoses in 2007. He blames the packaging of the drug for the mishap, with 10,000 unit and 10 unit heparin vials looking so similar that nurses confused them.  

Well, a heparin manufacturer has addressed that issue, and Tuesday asserted that its special labeling — with different  colors for each strength of heparin –  helped it to win Food and Drug Administration approval  for nine of its heparin products.
http://www.fiercepharmamanufacturing.com/story/packaging-contributes-approvals-sagents-heparin/2010-07-06

Sagent said it will launch its new heparin products, the heparin sodium injection USP,  immediately. In 2009 U.S. sales of heparin were about 306 million. 
http://www.pharmabiz.com/article/detnews.asp?articleid=56257&sectionid=

“Attaining FDA approval of Sagent’s heparin vials is a major accomplishment for our company,” CEO Jeffrey  Yordon said in a prepared statement. “Amidst the many challenges the nation’s supply of heparin has recently faced, Sagent identified and readied a reliable source for heparin and successfully navigated the FDA approval process for each of our heparin presentations. We believe that our innovative approach to the packaging and labelling of our heparin provides us with a significant advantage in the market by better meeting the requirements of patients and customers, positioning us for a successful launch.”

Sagent’s has proprietary PreventIV Measures packaging and labeling, which aids users in distinguishing between the nine presentations. Sagent’s packaging and labeling for heparin include using of a unique colour for each total strength; easy-to-read drug name, concentration and fill volumes; and cartons printed on all sides.

 PreventIV Measures is Sagent’s name for what it calls its user-driven and patient-centered approach to product labeling and packaging, which considers everyone handling medication along the way in order to help prevent medication errors.

“The pace of hospital care is faster than it has ever been, requiring increased vigilance to reduce treatment errors,”  Elaine Levy, system director for Pharmacy Sharp HealthCare in San Diego, California, said in a prepared statement.

 “Sagent’s PreventIV Measures approach to packaging and labeling design makes it easier to differentiate drugs from others in the same class, even when the medications look or sound alike,” she said. “Further, it makes it easier to distinguish between doses, which is especially important when working with medications like heparin that have a number of concentrations and sizes. I believe that features such as those incorporated into Sagent’s products can help reduce those errors caused by selecting the incorrect medication for a patient.”


PreventIV Measures is Sagent’s comprehensive, user-driven and patient-centred approach to product labelling and packaging that is designed to help prevent medication errors. It incorporates unique label and carton designs, cap and label colours, bar coding and other features that are designed to make it easier to differentiate drugs and identify the correct dose.


Attorney Gordon Johnson
Chair Traumatic Brain Injury Litigation Group, American Association of Justice
g@gordonjohnson.com :: 800-992-9447 :: Attorney Gordon S. Johnson, Jr.

http://subtlebraininjury.com :: http://brainanatomyguide.com :: http://car-accident-rain.com :: http://tbilaw.com
http://waiting.com :: http://vestibulardisorder.com :: http://youtube.com/profile?user=braininjuryattorney

Florida Jury Awards $2.4 Million In First Trial On Defective Chinese Drywall

0 comments

Posted on 21st June 2010 by gjohnson in Uncategorized

,

A verdict in the first jury trial involving defective Chinese drywall may be harbinger of what happens in thousands of similar cases, according to The Wall Street Journal.

 http://online.wsj.com/article/SB10001424052748704122904575315303116183036.html?KEYWORDS=chinese+drywall+judgment

 Last Friday a jury awarded $2.4 million in damages to a Florida couple because the imported drywall in their home emitted an odor so foul that they had to leave the dwelling. This type of Chinese drywall has been used in new homes throughout Florida and other states, areas that saw a building boom several years ago, before the market crashed.  

There have been a flood of complaints about the drywall giving off sulfurous fumes that have a rank smell, and that  have made residents ill and even damaged their appliances.

In the trial that just ended, a six-person jury found that Armin and Lisa Selfart were entitled to not only reimbursement for having to remove the drywall from their $1.6 million house, but also for damages for the loss of enjoyment of their home and for the difficulty they may have reselling it, according to The Journal.

 The award was against drywall distributor Banner Supply Co., which has been named as a defendent in thousands of lawsuits similar to the one filed by the Selfarts, The Journal reported.

An attorney for Banner told the newspaper that his client may appeal the jury verdict.

    

  


Attorney Gordon Johnson
Chair Traumatic Brain Injury Litigation Group, American Association of Justice
g@gordonjohnson.com :: 800-992-9447 :: Attorney Gordon S. Johnson, Jr.

http://subtlebraininjury.com :: http://brainanatomyguide.com :: http://car-accident-rain.com :: http://tbilaw.com
http://waiting.com :: http://vestibulardisorder.com :: http://youtube.com/profile?user=braininjuryattorney

FDA Hamstrung By Limited Resources, Uncoordinated Efforts, Report Says

0 comments

Posted on 9th June 2010 by gjohnson in Uncategorized

, , ,

Deadly peanuts, hamburgers that cripple people, lettuce that gets people sick have made recent headlines. And the question has always been why didn’t the Food and Drug Administration prevent these mishaps. Well, a report was released Tueaday that tries to explain the FDA’s failures, and to make suggestions for improvement.  

http://www.iom.edu/Reports/2010/Enhancing-Food-Safety-The-Role-of-the-Food-and-Drug-Administration/Report-Brief-Enhancing-Food-Safety-The-Role-of-the-Food-and-Drug-Administration.aspx

 The agency’s abilities to discover potential threats to food safety and prevent outbreaks of foodborne illness are hampered by its limited resources and a piecemeal approach to gathering and using information on risks, the report concludes. 

The report, done by the Institute of Medicine and National Research Council, is a lot to digest.

It says that to more proactively tackle food safety problems, the FDA should implement a risk-based approach in which data and expertise pinpoint where along the production, distribution, and handling chains there is the greatest potential for contamination and other problems, according to a press release issued on the document. 

 http://www8.nationalacademies.org/onpinews/newsitem.aspx?RecordID=12892

The agency would then be able to direct appropriate amounts of its resources and attention to those high-risk areas and increase the chances of catching problems before they turn into widespread outbreaks, said the committee that wrote the report.  

The report offers FDA a blueprint for developing a risk-based model, and outlines several organizational steps the agency should take to improve the efficiency of its many food safety activities, such as increasing coordination with state and other federal agencies that share responsibility for protecting the nation’s food supply. 

In addition, the report says Congress should consider amending the Federal Food, Drug, and Cosmetic Act to explicitly provide the authority FDA needs to fulfill its food safety mission.

 ”As recent illnesses traced to produce underscore, foodborne diseases cause significant suffering, so it’s imperative that our food safety system functions effectively at all levels,” committee chair Robert Wallace, professor at the College of Public Health, University of Iowa, Iowa City, said in a press release.

  “FDA uses some risk assessment and management tactics, but the agency’s approach is too often reactive and lacks a systematic focus on prevention,” Wallace said . ”Our report’s recommendations aim to help FDA achieve a comprehensive vision for proactively protecting against threats to the nation’s food supply.”

 The FDA is responsible for ensuring the safety of approximately 80 percent of the nation’s food supply, including seafood, dairy products, and fruits and vegetables.

 Although it is not the sole organization overseeing food safety — the U.S. Department of Agriculture handles meat, poultry, and egg products, and state and local agencies share in conducting food production facility inspections, surveillance, and investigations of outbreaks — recent outbreaks of foodborne illness led to a congressional request for a review of gaps in the FDA’s food safety system. 

The agency has been criticized for not adequately monitoring and inspecting food suppliers and distributors and for not taking a proactive approach to food safety overall, according to the official press release on the report.

 However, given that the FDA is responsible for more than 150,000 food facilities, more than 1 million restaurants and other retail food establishments, and more than 2 million farms, as well as millions of tons of imports, it lacks the resources to sufficiently monitor the entire food supply, the committee noted. 

 A risk-based approach would give the FDA’s food safety officials the strategic vision needed to evaluate and plan for food safety concerns rather than tackling problems on a case-by-case basis, the report says.

 Without good information, agency officials cannot identify where its resources are needed most or determine which policy interventions are most effective.  The FDA has insufficient analytical expertise and infrastructure to gather, manage, and use data effectively.  The agency should identify its data needs and review its policies for sharing data with other agencies and organizations. 

 The federal government should establish a centralized food safety data center outside of the regulatory agencies to collect information and conduct rapid, sophisticated assessments of food safety risks and appropriate policy interventions. 

This center would go a long way toward developing much-needed capacity and would reduce interagency competition for resources, the committee said.  It could also serve as an intermediate step toward consolidating food safety activities within a single agency, which many individuals and organizations have called for. 

 To enhance its efficiency, the FDA should explore alternative approaches to regulating food safety, such as delegating food facility inspections to the states, the report says. And the agency should establish national standards for the intensity and frequency of these facility reviews and help states and local municipalities bring their safety programs up to those standards. 

 Once all programs are standardized, the FDA should train and certify state inspectors with the goal of turning over the majority of inspections to them under the agency’s supervision.  This change would build on current practices in which roughly 60 percent of inspections are already conducted by state inspectors under contract with FDA.  This integration and leveraging of resources would increase the quality of inspections and eliminate duplication of effort, the committee said. 

Despite the dramatic developments in food production and distribution that have occurred over the years, the main statutory provisions under which the FDA carries out its food safety responsibilities remain largely unchanged, the report says. 

Although various provisions give the agency broad discretion and flexibility through which it has been able to control potential problems, there are instances in which the FDA lacks specific authority, which can make its actions vulnerable to court challenge, the report says.

 Congress should examine how the legislation could be revised to detail FDA’s authorities in facility registration, preventive controls, risk-based inspection, mandatory recall, reporting of adulteration, and banning of food imports if the public’s health is at risk, among other areas, according to the report.

Congress requested the report on the FDA. 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 


Attorney Gordon Johnson
Chair Traumatic Brain Injury Litigation Group, American Association of Justice
g@gordonjohnson.com :: 800-992-9447 :: Attorney Gordon S. Johnson, Jr.

http://subtlebraininjury.com :: http://brainanatomyguide.com :: http://car-accident-rain.com :: http://tbilaw.com
http://waiting.com :: http://vestibulardisorder.com :: http://youtube.com/profile?user=braininjuryattorney

After $500 Million Judgment, Teva Says It Will Stop Making The Anesthetic Propofol

0 comments

Posted on 29th May 2010 by gjohnson in Uncategorized

, , , , ,

Less than a month after a jury ordered Teva Pharmaceutical Industries to pay $360 million in a product liability/negligence case involving propofol, the drug giant said it will stop making the anesthetic. http://online.wsj.com/article/SB10001424052748704269204575270900368773506.html?KEYWORDS=Teva+and+propofol

In a statement to federal regulators last week, Teva announced it was stopping production of propofol, according to The Wall Street Journal. 

It’s no wonder that Teva is dropping the drug, which has been under fire by federal officials and consumers alike.

 Most recently, just earlier this month, Teva and Baxter Health Care Corp. lost a suit filed by a Nevada man who contracted hepatitis C  after undergoing a routine colonoscopy where he was anesthesized with propofol. 

 http://heparin-law.com/blog/2010/05/jury-orders-baxter-teva-to-pay-500-million-in-largest-award-in-nevada%e2%80%99s-history.html?preview=true&preview_id=528&preview_nonce=f654a8d83e

 In that case, a jury in Las Vegas awarded Henry Chanin and his wife half a billion dollars in punitive damages, the largest award in Nevada’s history. Teva was ordered to pay $356 million, while Baxter was hit for $144 million.

As many as 114 patients were infected with hepatitis C, when medical workers used single-dose vials of propofol on more than one patient, spreading the incurable disease to those undergoing colonoscopies. Chanin’s lawyer is representing 40 other patients who contracted hepatitis from the vials, and another 4,500 who were among 50,000 who got notices that they may have been exposed to hepatitis during their colonoscopies. 

Teva has had other problems with propofol. The pharmaceutical company had to recell some of the anesthetic last July when high levels of toxins wre found at its Irvine, Calif., plant. The Food and Drug Administration in a letter in December told Teva that it had found “significant” violations at that plant, according to The Journal.

In its statement last week saying it was ending its manufacturing of propofol, Teva said, “Our data supports that these products, when used and stored as directed, continue to be safe and effective and perform within the appropriate specifications.”

Propofol and a combination of other drugs were blamed for causing the death of singer Michael Jackson, who used the anesthetic to help him sleep.

Propofol is widely used for surgeries across the country, and federal officials have been worried that there might be a shortage of the anesthetic. So Teva’s news has federal regulators worried, despite the past problems the drug maker and the FDA have had over the drug.

  

 

 


Attorney Gordon Johnson
Chair Traumatic Brain Injury Litigation Group, American Association of Justice
g@gordonjohnson.com :: 800-992-9447 :: Attorney Gordon S. Johnson, Jr.

http://subtlebraininjury.com :: http://brainanatomyguide.com :: http://car-accident-rain.com :: http://tbilaw.com
http://waiting.com :: http://vestibulardisorder.com :: http://youtube.com/profile?user=braininjuryattorney

Bagged Romaine Lettuce Recalled Over Possible Salmonella Contamination

0 comments

Posted on 25th May 2010 by gjohnson in Uncategorized

, ,

Here’s the second romaine lettuce recall in about a week, this one involving salmonella.

Monday Fresh Express, a unit of Chiquita Brands International, recalled a variety of its Fresh Express Romaine-based ready-to-eat salads with the expired use-by dates of May 13 through May 16 and an “S” in the product code because they may be contaminated with salmonella. http://www.fda.gov/Safety/Recalls/ucm213247.htm

 There was just a romaine lettuce recall involving produce that had E. coli, Roughly 30 people got sick in that outbreak. 

The Fresh Express recall extends only to products with the specified Use-by Dates and product codes and sold in the following states: Michigan, Minnesota, Wisconsin, Louisiana, Nebraska, Montana, Missouri, Iowa, Kansas, Oklahoma, Arkansas, Nevada, Arizona, California, Colorado, New Mexico, Texas, Oregon, Washington, Alaska, Hawaii, Idaho, Utah, Wyoming, North Dakota and South Dakota.

No other Fresh Express salads are included in the recall.

“The recall notification is being issued out of an abundance of caution based on an isolated instance in which a single package of Fresh Express Hearts of Romaine Salad with a use by date of May 15 was confirmed positive for salmonella in a random sample test conducted by the U.S. Food and Drug Administration,” the press release on the recall said.

Salmonella is an organism that may cause fever, nausea, vomiting, abdominal pain and possibly bloody diarrhea in healthy individuals. It can cause serious and sometimes fatal infections in young children, frail or elderly people, and others with weakened immune systems.

Because it is still possible that products bearing the Use-by Dates of May 13 to 16 and an “S” in the product code could be on store shelves, the recall extends to retailers as well as consumers.

 Fresh Express claimed it was ”highly unlikely” that any of the potentially affected salads are still on store shelves or for sale to consumers due to the expired Use-by Dates, but said it wants to alert consumers who might still possess one of the potentially affected expired salads to immediately dispose of it.

Fresh Express is cooperating with the FDA,  and after learning of  the single confirmed positive test ran and completed a companywide product traceability review.

 


Attorney Gordon Johnson
Chair Traumatic Brain Injury Litigation Group, American Association of Justice
g@gordonjohnson.com :: 800-992-9447 :: Attorney Gordon S. Johnson, Jr.

http://subtlebraininjury.com :: http://brainanatomyguide.com :: http://car-accident-rain.com :: http://tbilaw.com
http://waiting.com :: http://vestibulardisorder.com :: http://youtube.com/profile?user=braininjuryattorney

Alfalfa Sprouts Recalled After Salmonella Outbreak In 10 States

0 comments

Posted on 23rd May 2010 by gjohnson in Uncategorized

, ,

 Just about two weeks ago, Americans were at risk of being sickened by romaine lettuce with E. coli. Last week, raw alfalfa sprouts carrying salmonella were the health culprit. We can’t help but wonder why federal food regulators don’t seem capable of protecting U.S. consumers.

There was a nationwide recall of raw alfalfa sprouts after roughly 22 people in 10 states got ill from what is normally considered a very healthy food stuff. http://www.aolnews.com/nation/article/salmonella-outbreak-sickens-people-in-10-states/19487557irst

Caldwell Fresh Foods of Los Angeles Friday recalled the alfalfa that is sells under the brand names Caldwell Fresh Foods, Nature’s Choice and California Exotics.

Caldwell company officials said that alfalfa sprouts are controlled by the Food and Drug Administration, and that they had followed all that agency’s guidelines.

The recalled sprouts had been sent to restaurants, as well as being sold to grocery stores, such as Trader Joe’s and Wal-Mart.

 Of the 22 people who had symptoms of salmonella after eating alfalfa sprouts, six had to go the hospital. Cases were reported in California, Wisconsin, Nevada, Arizona, Oregon, Idaho, Illinois, Missouri, New Mexico and Colorado.  

 Those who contract salmonella typically suffer from abdominal pains, fever and diarrhea anywhere from 12 to 72 hours after being infected.

Alfalfa spouts can pick up bacteria because they are grown in a damp environment.    

Earlier this month, more than two dozen people got sick afte eating romaine lettuce contaminated with E. coli. That lettuce was recalled. 


Attorney Gordon Johnson
Chair Traumatic Brain Injury Litigation Group, American Association of Justice
g@gordonjohnson.com :: 800-992-9447 :: Attorney Gordon S. Johnson, Jr.

http://subtlebraininjury.com :: http://brainanatomyguide.com :: http://car-accident-rain.com :: http://tbilaw.com
http://waiting.com :: http://vestibulardisorder.com :: http://youtube.com/profile?user=braininjuryattorney

Teva, Baxter Acted Out of Corporate Greed, Sparking The Biggest Recorded Hepatitis Outbreak In History

0 comments

Posted on 12th May 2010 by gjohnson in Uncategorized

, , , , ,

Last week a Las Vegas jury delivered the largest award ever, $500 million, in the state of Nevada’s history. That’s a very generous verdict, rendered – I think – because the panel believed that two giant drug companies valued their profits much more than the public’s safety.   http://www.lasvegassun.com/news/2010/may/07/jurors-reach-verdict-over-hepatitis-c-damages/

As I wrote in a blog yesterday, the judgment was awarded in a case where a man in his 60s went to a clinic in 2006 for what should have been a routine colonoscopy. He left with an incurable liver disease, hepatitis C.  

That man, Henry Chanin, and his wife Lorraine won $356 million in punitive damages from Teva Parenteral Medicines and $144 million from Baxter Health Care, the manufacturer and distributor, respectively, of the anesthetic propofol. Teva and Baxter plan to appeal the verdict.

The case raises many questions about corporate responsibility and safety.  Baxter is no strange to such questions. It faces a flood of lawsuits from survivors of people, estimated in the hundreds, who died after getting doses of contaminated heparin, a blood thinner, that was imported to the states from China in 2008. 

Last week’s $500 million verdict is only the beginning for Teva and Baxter. There are dozens of lawsuits stemming from the hepatitis C outbreak pending against the two pharmaceutical giants, but the Chanins’ case was the first to go to trial. After the award in their trial, if I was representing Teva and Baxter, I would advise them to settle those other lawsuits, pronto.  

Patients at several facilities, including the Desert Shadow Endoscopy Center, were exposed to HIV and hepatitis strains C and B when single-dose vials of propofol were used on multiple patients after the vials had been contaminated by nurses reusing syringes on the same patients.

During the opening statements in April for the four-week trial on the Chanins’ lawsuit, attorneys told the jury that Teva and Baxter’s negligent actions sparked the largest recorded hepatitis outbreak in history. http://www.lvrj.com/news/lawer-targets-drug-companies-in-hepatitis-case-opening-statements-91533874.html

 Henry Chanin’s lawyer, Robert Eglet, said that a company called SICOR Pharmaceuticals opted to sell propofol in 20 milliliter and 100-milliter vials in order to boost its production and profits. As a result, SICOR was sold at a premium price, $3.5 billion, to Teva in 2003.

 But there was a problem with the 50-millimeter vials: That large a dose was enough to knock out a 600-pound gorilla, an anesthesiologist testified at the trial. A human would only need to get 10 to 20 milliliters of the drug in order to undergo a colonoscopy.  http://www.lvrj.com/news/doctor-in-endoscopy-trial-testifies-vials-of-sedative-were-too-large-91684569.html

 Rather than throw out the leftover propofol in a vial, medical workers were tempted to re-use the single-use vials, which became contaminated when nurses reused syringes on the same patient.

 ”The pharmaceutical companies were responsible for providing 50 milliliter vials of propofol to ambulatory centers that would require no more than 10 milliliter to 20 milliliter bottles because profit dictated the decision to do so,” Eglet said in a statement after the jury’s verdict. “The larger size vials encouraged multi-dosing becoming weapons of mass infection.”

Teva and Baxter could have remedied the situation. Eglet pointed out that there were 148 reported cases of hepatitis C contamination throughout the U.S. and globally – all before Chanin contracted the disease – and yet Teva and Baxter didn’t take any action. If they had, Chanin would not have the chronic liver disease today. 

It was also unfortunate for those who became infected in Nevada because of “double-dipping” in those large vials.

 Teva and Baxter were acting out of greed, the public be damned. So many, many people because infected in Nevada, all because of nurses “double-dipping” in those large, cost-effective vials.

 Even though the $500 million award is a tidy sum, it’s almost a drop in the bucket to Teva and Baxter, which combined made $13.4 billion last year.

 “The $500 million verdict represents two weeks of income to these companies,” Eglet said. “The jury understood the importance of sending a message to stop putting profit over patient safety and making sure this never happens again.”


Attorney Gordon Johnson
Chair Traumatic Brain Injury Litigation Group, American Association of Justice
g@gordonjohnson.com :: 800-992-9447 :: Attorney Gordon S. Johnson, Jr.

http://subtlebraininjury.com :: http://brainanatomyguide.com :: http://car-accident-rain.com :: http://tbilaw.com
http://waiting.com :: http://vestibulardisorder.com :: http://youtube.com/profile?user=braininjuryattorney

Jury Orders Baxter, Teva to Pay $500 Million In Largest Award in Nevada’s History

0 comments

Posted on 11th May 2010 by gjohnson in Uncategorized

, , , , , , ,

 Baxter Health Care Corp. and Teva Parenteral Medicines were asked to pay a mere $1.7 million to settle a lawsuit filed against them by a Nevada man who contracted hepatitis C after undergoing a routine colonoscopy. The two drug giants ignored the offer, according to Robert Eglet, the plaintiff’s attorney. http://www.lasvegassun.com/news/2010/may/07/jurors-reach-verdict-over-hepatitis-c-damages/

 Well, hindsight is 20/20, as they say. That’s because last Friday a Clark County District Court jury in Nevada awarded Henry Chanin and his wife a half a billion dollars in punitive damages. Teva was ordered to fork over $356 million and Baxter was hit for $144 million, a whopping $500 million total.

 That’s the largest award in Nevada’s history.

 The Chanins’ complaint against Teva and Baxter alleged product liability, negligence and disregard of known and accepted medical procedures, resulting in Henry Chanin contracting hepatitis C from exposure to contaminated vials of the anesthetic propofol. Baxter was the distributor and Teva the manufacturer of the drug.

 This hepatitis case isn’t the only litigation that Baxter has pending against it. The drug maker also faces a barrage of lawsuits stemming from hundreds of people dying after taking tainted heparin, the blood thinner, that had been imported from China in 2008.

 Both Baxter and Teva said they plan to appeal the $500 million jury verdict in Nevada, which stems from a hepatitis C outbreak two years ago.

 Patients were exposed to HIV and hepatitis strains C and B when single-dose vials of anesthesia medication, propofol, were used on multiple patients.  Nurse anesthetists were re-used syringes to withdraw medication from the single-dose vial, creating a back flow of blood resulting in contamination. http://www.lvrj.com/news/teva-plans-appeal-of-hepatitis-verdict-93223949.html

 Teva maintains that it has done nothing wrong.

 “Teva is reviewing the full judgment and continues to believe that the evidence shows the company acted responsibly,” the drug maker said in a statement.

 “The label for its propofol product clearly states that it is for single patient use only and that aseptic procedures should be used at all times. “ Teva said. “Further, the company believes that the Jury should have been allowed to hear all of the evidence in this case. Teva believes that the evidence clearly showed that if the plaintiff contracted hepatitis as alleged, it was because a properly labeled product was blatantly misused at the clinic in question. Teva believes that there are numerous grounds for appeal, and plans to contest the verdict vigorously.”

 Anywhere from nine to 114 patients were infected with the incurable disease. In addition to Chanin, Eglet represents 40 more patients who contracted hepatitis C and another 4,500 who were among the 50,000 people who had gotten colonoscopies at the Nevada clinic in question and were notified that they needed to be tested. Not the kind of message you ever want to get.

 Chanin’s story is particularly heartbreaking, which is perhaps why the Nevada jury was so generous. He is the headmaster of The Meadows School, a private school founded by Carolyn Goodman, wife of Las Vegas Mayor Oscar Goodman.

 Chanin went to the Desert Shadow Endoscopy Center in June 2006 for a colonoscopy, and in addition to having that routine procedure he contracted hepatitis C.

 During a four-week trial that started April 19, Chanin said that he and his wife had stopped having sexual relations, for fear that he would spread the disease to her.

 ”A $1.7 million offer of judgment to settle was ignored by the defense bringing the Chanin’s to this point,” Eglet said in a press release.

 “At the core of this case is the responsibility of the pharmaceutical companies as well as that of the health care professionals,” he said. “The conduct of the doctors and nurses demonstrated a disregard for human life in the reuse of contaminated vials and syringes. Equally, the pharmaceutical companies were responsible for providing 50 ml vials of propofol to ambulatory centers that would require no more than 10ml to 20 ml bottles because profit dictated the decision to do so. The larger size vials encouraged multi-dosing becoming weapons of mass infection. The result is nearly immeasurable.”

Before Friday’s verdict, Henry and his wife had already been awarded compensatory damages of $3.25 million and $1.85 million, respectively. 

I’ll be writing more about the details of this case, and the significance of the vial sizes, this week.


Attorney Gordon Johnson
Chair Traumatic Brain Injury Litigation Group, American Association of Justice
g@gordonjohnson.com :: 800-992-9447 :: Attorney Gordon S. Johnson, Jr.

http://subtlebraininjury.com :: http://brainanatomyguide.com :: http://car-accident-rain.com :: http://tbilaw.com
http://waiting.com :: http://vestibulardisorder.com :: http://youtube.com/profile?user=braininjuryattorney

Chinese Drug Maker Untainted By 2008 Heparin Tragedy Makes Strong Financial Debut

0 comments

Posted on 7th May 2010 by gjohnson in Uncategorized

, , ,

The world’s largest supplier of heparin products, which is also the only Chinese heparin maker accredited by the Food and Drug Administration, has become a publicly traded company. It got off to such a strong start that its founders have become “overnight” multi-billionaires.  http://www.nytimes.com/2010/05/07/business/global/07drug.html?scp=2&sq=heparin&st=Search

If you believe the claims of Shenzen Hepalink Pharmaceutical, which started trading on the Shenzen stock exchange Thursday, it is one of the few good guys, one of the few Chinese heparin makers with its hands clean, in the tragedy in 2008 when contaminated heparin imported from China was linked to the deaths of hundreds in the United States.

Shenzen Hepalink claims that it not only has accreditation from the FDA, but also from the European Directorate for the Quality of Medicines and Healthcare.

Officials at Shenzen Hepalink underpriced their initial public offering, as the company’s shares jumped 18.3 percent from the opening price. That put the drug maker’s valuation at $10 billion, and made very rich men of its founders, Li Li and his wife Tan Li.

The New York Times Friday described Shenzen Hepalink’s main product as “highly purified heparin, a substance made from the mucous membranes of pig intestines.”  Heparin is a blood thinner. 

The Times suggested that the reason Shenzen Hepalink’s shares did so well their first day on the market was because the company was guiltless, and never cited, as one of the Chinese companies that provided contaminated heparin to the states. Tainted heparin from 12 Chinese companies was sent to nearly a dozen countries, according to The Times.   

The paper also pointed out that in China, “pig intestines are often cooked in unregulated family workshops.” In 2008, a contaminant called oversulfated chondroitin sulfate was in the tainted heparin, undetected by normal testing.

The Food and Drug Administration has said that there were 149 deaths caused by allergic reactions to the contaminated heparin, according to The Times.

That’s way below our estimate. We believe that hundreds of deaths can be linked to the tainted heparin, and there are hundreds of wrongful-death suits pending in the matter. 

 Here’s a side note to this story. Another investor that did very well with Shenzhen Hepalink’s IPO was beleaguered Goldman Sachs. It paid $4.9 million for a 12.5 percent share in the heparin company back in 2007. That stake is now worth 200 times what Goldman first paid for it, according to Bloomberg News.   

    

 

      

 


Attorney Gordon Johnson
Chair Traumatic Brain Injury Litigation Group, American Association of Justice
g@gordonjohnson.com :: 800-992-9447 :: Attorney Gordon S. Johnson, Jr.

http://subtlebraininjury.com :: http://brainanatomyguide.com :: http://car-accident-rain.com :: http://tbilaw.com
http://waiting.com :: http://vestibulardisorder.com :: http://youtube.com/profile?user=braininjuryattorney

Lettuce Recalled In 23 States After E. Coli Outbreak

0 comments

Posted on 7th May 2010 by gjohnson in Uncategorized

, , , , , , ,

Here’s more evidence that we need stronger food safety laws: There has been a recall of E. coli-tainted  lettuce that was sold in 23 states and the District of Columbia. So far, 19 people have gotten ill, with three of them having “life-threatening symptoms.” http://www.google.com/hostednews/ap/article/ALeqM5hEnc00D5YgQjLxbZqLLkjOw_fwzgD9FI2MS01

Freshway Foods of Sidney, Ohio, issued the recall for the romaine lettuce it sold under the names Freshway and Imperial Sysco because it’s believed the lettuce is linked to the E. coli outbreak.

The Food and Drug Administration said Thursday that 12 people had to be hospitalized, and 10 other cases were being investigated by the Centers for Disease Control. College students at the University of Michigan in Ann Arbor, Ohio State in Columbus and Daemen College in Amherst, N.Y., were among those striken in the E. coli outbreak.  

 Sources told the Associated Press that the FDA suspects that the E. coli outbreak is being caused by lettuce grown in Arizona.  

Whether the problem is contaminated peanuts or lettuce, there needs to be stricter laws involving the safety of what we eat. The House did its part, when it passed a bill last year that gives the FDA more authority to monitor food production. However, the Senate has yet to act on that bill.

So in the meantime, people get sick and may even die because of this tainted lettuce, which was sold to wholesalers, food service outlets, salad bars and delis. The three who had life-threatening symptoms were suffering from hemolytic uremic syndrome, which can lead to bleeding in the kidney and brain.

One reason why the E. coli contaminating the lettuce may not have been detected is because it is E. coli 0145, not the most common strain of E. coli 0517. The strain on the lettuce is harder to detect, according to the CDC.

The first to discover the source of the E. coli outbreak was the New York Public Health Laboratory in Albany, which found the bacteria in a bag of Freshway Foods shredded romaine lettuce on Wednesday.    

 Perhaps this latest outbreak will prompt the Senate to act on the food-safety legislation that’s been sitting before it.  


Attorney Gordon Johnson
Chair Traumatic Brain Injury Litigation Group, American Association of Justice
g@gordonjohnson.com :: 800-992-9447 :: Attorney Gordon S. Johnson, Jr.

http://subtlebraininjury.com :: http://brainanatomyguide.com :: http://car-accident-rain.com :: http://tbilaw.com
http://waiting.com :: http://vestibulardisorder.com :: http://youtube.com/profile?user=braininjuryattorney